A lifelong model for the female reproductive cycle with an antimüllerian hormone treatment to delay menopause

Journal of Theoretical Biology

Volumn 326, Issue , 2013, Pages 21-35

  Margolskee, Alison ^a   Selgrade, James F ^a  

^a NORTH CAROLINA STATE UNIVERSITY   (United States)

Author keywords

Menstrual cycle; Parameter identification; Primordial follicle

Indexed keywords

ESTRADIOL; FOLLITROPIN; HORMONE ANTAGONIST; HORMONES AND HORMONE ANALOGS; INHIBIN A; LUTEINIZING HORMONE; MUELLERIAN INHIBITING FACTOR; MUELLERIAN INHIBITING FACTOR AGONIST; MUELLERIAN INHIBITING FACTOR ANTAGONIST; PROGESTERONE; UNCLASSIFIED DRUG;

HORMONE; MODELING; REPRODUCTIVE CYCLE; WOMENS HEALTH;

AGE; ARTICLE; CONTRACEPTION; DOSE RESPONSE; DRUG DOSE COMPARISON; FEMALE INFERTILITY; HORMONAL REGULATION; HUMAN; MATHEMATICAL MODEL; MENOPAUSE; NONLINEAR SYSTEM; OVARY CYCLE; OVARY DEVELOPMENT; OVARY FOLLICLE; OVULATION INDUCTION; PREDICTION; PREMENOPAUSE; PRIORITY JOURNAL; TREATMENT OUTCOME;

ADULT; ANTI-MULLERIAN HORMONE; COMPUTER SIMULATION; FEMALE; HUMANS; LONGEVITY; MENOPAUSE; MENSTRUAL CYCLE; MIDDLE AGED; MODELS, BIOLOGICAL; PRIMARY OVARIAN INSUFFICIENCY; REPRODUCTION; TIME FACTORS; YOUNG ADULT;

EID: 84875491967     PISSN: 00225193     EISSN: 10958541     Source Type: Journal    
DOI: 10.1016/j.jtbi.2013.02.007     Document Type: Article

References (57)

1. Banks, H.T., Davidian, M., Samuels, J.R., 2007. An inverse problem statistical methodology summary, http://www.ncsu.edu/crsc/reports/ftp/pdf/crsc-tr07-14.pdf.
2. Bogumil R.J., Ferin M., Rootenberg J., Speroff L., Vande-Wiele R.L. Mathematical studies of the human menstrual cycle. I. Formulation of a mathematical model. J. Clin. Endocrinol. Metab. 1972, 35:126-143.
3. Bogumil R.J., Ferin M., Vande-Wiele R.L. Mathematical studies of the human menstrual cycle II. simulation of a model of the human menstrual cycle. J. Clin. Endocrinol. Metab. 1972, 35:144-156.
4. Broekmans F.J., Faddy M.J., Scheffer G., te Velde E.R. Antral follicle counts are related to age at natural fertility loss and age at menopause. J. North Am. Menopause Soc. 2004, 11(6):607-614.
5. Broekmans F.J., Soules M.R., Fauser B.C. Ovarian aging. mechanisms and clinical consequences. Endocr. Rev. 2009, 30:465-493.
6. Burger H.G., Hale G.E., Robertson D.M., Dennerstein L. A review of hormonal changes during the menopausal transition. focus on findings from the Melbourne Women's Midlife Health Project. Hum. Reprod. Update 2007, 13(6):559-565.
7. Cacuci D.G. Sensitivity and Uncertainty Analysis Theory 2003, Chapman & Hall/CRC, Boca Raton.
8. Cobel Y.D., Kohler P.O., Cargille C.M., Ross G.T. Production rates and metabolic clearance rates of human follicle-stimulating hormone in premenopausal and postmenopausal women. J. Clin. Investig. 1969, 48:359-363.
9. Deuflhard P. Newton Methods for Nonlinear Problems-Affine Invariance and Adaptive Algorithms 2004, Springer-Verlag, Berlin.
10. Durlinger A.L.L., Visser J.A., Themmen A.P. Regulation of ovarian function. the role of anti-mullerian hormone. Reproduction 2002, 601-609.
11. Hagen C.P., Aksglaede L., Sorensen K., Main K.M., Boas M., Cleemann L., Holm K., Gravholt C.H., Andersson A., Pedersen A.T., Petersen J.H., Linneberg A., Kjaergaard S., Juul A. Serum levels of anti-mullerian hormone as a marker of ovarian function in 926 healthy females from birth to adulthood and in 172 Turner syndrome patients. J. Clin. Endocrinol. Metab. 2010, 95:5002-5010.
12. Hale G.E., Zhao X., Hughes C.L., Burger H.G., Robertson D.M., Fraser I.S. Endocrine features of menstrual cycles in middle and late reproductive age and the menopausal transition classified according to the staging of reproductive aging workshop (STRAW) staging system. J. Clin. Endocrinol. Metab. 2007, 92:2060-3067.
13. Hampl R., Snajderova M., Mardesic T. Antimullerian hormone (AMH) not only a marker for prediction of ovarian reserve. Physiol. Res. 2011, 60:217-223.
14. Hansen K.R., Knowlton N.S., Thyer A.C., Charleston J.S., Soules M.R., Klein N.A. A new model of reproductive aging. the decline in ovarian non-growing follicle number from birth to menopause. Hum. Reprod. 2008, 23(3):699-708.
15. Harris-Clark L., Schlosser P.M., Selgrade J.F. Multiple stable periodic solutions in a model for hormonal control of the menstrual cycle. Bull. Math. Biol. 2003, 65:157-173.
16. Hudson P.L., Dougas I., Donahoe P.K., Cat R.L., Epstein J., Pepinsky R.B., MacLaughlin D.T. An immunoassay to detect human mullerian inhibiting substance in males and females during normal development. J. Clin. Endocrinol. Metab. 1990, 70:16-22.
17. Karsch F.J., Dierschke D.J., Weick R.F., Hotchkiss J., Yamaji T., Knobil E. Positive and negative feedback control by estrogen of luteinizing hormone secretion in the rhesus monkey. Endocrinology 1973, 92:799-804.
18. Keener J., Sneyd J. Mathematical Physiology I. Cellular Physiology 2009, Springer-Verlag, New York. 2nd ed.
19. Kelley C.T. Iterative Methods for Optimization, Frontiers in Applied Mathematics 1999, vol. 18. SIAM, Philadelphia.
20. Kohler P.O., Ross G.T., Odell W.D. Metabolic clearance and production rates of human luteinizing hormone in pre- and postmenopausal women. J. Clin. Investig. 1968, 47(1):38-47.
21. La Marca A., Stabile G., Carducci Artenisio A., Volpe A. Serum anti-mullerian hormone throughout the human menstrual cycle. Hum. Reprod. 2006, 21(12):3103-3107.
22. Lee M.M., Donahoe P.K., Hasegawa T., Silverman B., Crist G.B., Best S., Hasegawa Y., Noto R.A., Schoenfeld D., MacLaughlin D.T. Mullerian inhibiting substance in humans. normal levels from infancy to adulthood. J. Clin. Endocrinol. Metab. 1996, 81:571-576.
23. Liu J.H., Yen S.S.C. Induction of midcycle gonadotropin surge by ovarian steroids in women. a critical evaluation. J. Clin. Endocrinol. Metab. 1983, 57:797-802.
24. Maciel G.A.R., Baracat E.C., Benda J.A., Markham S.M., Hensinger K., Chang R.J., Erickson G.F. Stockpiling of transitional and classic primary follicles in ovaries of women with polycystic ovary syndrome. J. Clin. Endocrinol. Metab. 2004, 89:5321-5327.
25. Margolskee, A., 2012. ddeRK4 http://www4.ncsu.edu/~amargol/research/ddeRK4.html.
26. Margolskee A., Selgrade J.F. Bifurcation analysis of a model for hormonal regulation of the menstrual cycle with inhibin delay. Math. Biosci. 2011, 234:95-107.
27. McLachlan R.I., Cohen N.L., Dahl K.D., Bremner W.J., Soules M.R. Serum inhibin levels during the periovulatory interval in normal women. relationships with sex steroid and gonadotrophin levels. Clin. Endocrinol. 1990, 32:39-48.
28. Nussey S.S., Whitehead S.A. Endocrinology. An Integrated Approach 2001, Taylor & Francis, London.
29. Odell W.D. The reproductive system in women. Endocrinology 1979, 1383-1400. Grune & Stratton, New York. L.J. DeGroot (Ed.).
30. Ojeda, S.R., 1992. Female reproductive function. In: Griffin, J.E., Ojeda, S.R. (Eds.), Textbook of Endocrine Physiology. Oxford University Press, Oxford, 2nd ed., pp. 134-188.
31. Olufsen, M., Ottesen, J.T. A practical approach to parameter estimation applied to model predicting heart rate regulation, J. Math. Biol., in press.
32. Ott R.L., Longnecker M. An Introduction to Statistical Methods and Data Analysis 2010, Brooks/Cole Cengage Learning. 6th ed.
33. Pasteur, R.D., 2008. A multiple-inhibin model for the human menstrual cycle. Ph.D. Thesis, North Carolina State University, Raleigh, North Carolina http://www.lib.ncsu.edu/resolver/1840.16/5587.
34. Plouffe L., Luxenberg S.N. Biological modeling on a microcomputer using standard spreadsheet and equation solver programs. the hypothalamic-pituitary-ovarian axis as an example. Comput. Biomed. Res. 1992, 25:117-130.
35. Ralston A., Rabinowitz P. A First Course in Numerical Analysis 1978, Mcgraw-Hill, New York. 2nd ed.
36. Reddy P., Zheng W., Liu K. Mechanisms maintaining the dormancy and survival of mammalian primordial follicles. Trends Endocrinol. Metabol. 2009, 21:96-103.
37. Reinecke I., Deuflhard P. A complex mathematical model of the human menstrual cycle. J. Theor. Biol. 2007, 247:303-330.
38. Robertson D.M., Hale G.E., Fraser I.S., Hughes C.L., Burger H.G. A proposed classification system for menstrual cycles in the menopause transition based on changes in serum hormone profiles. Menopause. J. North Am. Menopause Soc. 2008, 15(6):1139-1144.
39. Schlosser P.M., Selgrade J.F. A model of gonadotropin regulation during the menstrual cycle in women. qualitative features. Environ. Health Perspect. 2000, 108(Suppl. 5):873-881.
40. Selgrade J.F., Schlosser P.M. A model for the production of ovarian hormones during the menstrual cycle. Fields Inst. Commun. 1999, 21:429-446.
41. Shampine L.F., Thompson S. Solving DDEs in MATLAB. Appl. Numer. Math. 2001, 37:441-458.
42. Skinner M.K. Regulation of primordial follicle assembly and development. Hum. Reprod. Update 2005, 11(5):461-471.
43. Sonin A.A. The Physical Basis of Dimensional Analysis 2001, Dept. Mech. Eng. MIT. 2nd ed.
44. Soules M.R., Sherman S., Parrott E., Rebar R., Santoro N., Utian W., Woods N. Stages of reproductive aging workshop (STRAW). J. Womens Health Gender-Based Med. 2001, 10:843-848.
45. Sowers M., McConnel D., Gast K., Zheng H., Nan B., McCarthy J.D., Randolph J.F. Anti-Mullerian hormone and inhibiin B variability during normal menstrual cycles. Fertil. Steril. 2010, 94(4):1482-1486.
46. Sowers M.R., Eyvazzadeh A.D., McConnell D., Yosef M., Jannausch M.L., Zhang D., Harlow S., Randolph J.F. Anti-mullerian hormone and inhibin B in the definition of ovarian aging and the menopause transition. J. Clin. Endocrinol. Metab. 2008, 93:3478-3483.
47. Tehrani F.R., Solaymani-Dodaran M., Hedayati M., Azizi F. Is polycystic ovary syndrome an exception for reproductive aging?. Hum. Reprod. 2010, 25:1775-1781.
48. van Beek R.D., van den Heuvel-Eibrink M.M., Laven J.S.E., de Jong F.H., Themmen A.P.N., Hakvoort-Cammel F.G., van den Bos C., van den Berg H., Pieters R., de Muinck Keizer-Schrama S.M.P.F. Anti-mullerian hormone is a sensitive serum marker for gonadal function in women treated for Hodgkin's lymphoma during childhood. J. Clin. Endocrinol. Metab. 2007, 92:3189-3874.
49. van Disseldorp J., Faddy M.J., Themmen A.P.N., de Jong F.H., Peeters P.H.M., van der Schouw Y.T., Broekmans F.J.M. Relationship of Serum antimullerian hormone concentration to age at menopause. J. Clin. Endocrinol. Metab. 2008, 93:2129-2134.
50. van Zonneveld P., Scheffer G.J., Broekmans F.J.M., Blankenstein M.A., de Jong F.H., Looman C.W.N., Habbema J.D.F., te Velde E.R. Do cycle disturbances explain the age-related decline of female fertility? Cycle characteristics of women aged over 40 years compared with a reference population of young women. Hum. Reprod. 2003, 18:495-501.
51. Visser J.A., deJong F.H., Laven J.S.E., Themmen A.P.N. Anti-mullerian hormone. a new marker for ovarian function. Soc. Reprod. Fertil. 2006, 131:1-9.
52. Welt C.K., McNicholl D.J., Taylor A.E., Hall J.E. Female reproductive aging is marked by decreased secretion of dimeric inhibin. J. Clin. Endocrinol. Metab. 1999, 84:105-111.
53. White Y.A.R., Woods D.C., Takai Y., Ishihara O., Seki H., Tilly J.L. Oocyte formation by mitotically active germ cells purified from ovaries of reproductive-age women. Nat. Med. 2012, 18(3):413-421.
54. Wunder D.M., Bersinger N.A., Yared M., Kretschmer R., Birkhauser M.H. Statistically significant changes of antimullerian hormone and inhibin levels during the physiologic menstrual cycle in reproductive age women. Fertil. Steril. 2008, 89:927-933.
55. Yen, S.S.C., 1991. The human menstrual cycle: neuroendocrine regulation. In: Yen, S.S.C., Jaffe, R.B., Barbieri, R.L. (Eds.), Reproductive Endocrinology: Physiology, Pathophysiology and Clinical Management. W.B. Saunders Co, Philadelphia, 4th ed., 1999, pp. 191-217.
56. Zeleznik A.J. The physiology of follicle selection. Reprod. Biol. Endocrinol. 2004, 2:31.
57. Zuse Institut Berlin: Numerical Analysis and Modelling - NewtonLib http://www.zib.de/en/numerik/software/newtonlib.html.